OMass Therapeutics
OMass Therapeutics is a pre-clinical biotech company utilising a new drug discovery platform incorporating native mass spec and proprietary chemistry that allows drug design against previously 'undruggable' targets.
- What
- Life Sciences
- When
- Mar 2016
- CEO
- Ros Deegan
- Status
- Private
- Investment
- Active
- OSE Board Director
- Chris Ashton